Publications by the researcher in collaboration with Carolina Zandueta Pascual (24)

2022

  1. Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer

    Cancer Discovery, Vol. 12, Núm. 5, pp. 1356-1377

2020

  1. Combinatorial nanomedicine made of squalenoyl-gemcitabine and edelfosine for the treatment of osteosarcoma

    Cancers, Vol. 12, Núm. 7, pp. 1-13

2018

  1. Blockade of the complement C5a/C5aR1 axis impairs lung cancer bone metastasis by CXCL16-mediated effects

    American Journal of Respiratory and Critical Care Medicine, Vol. 197, Núm. 9, pp. 1164-1176

2017

  1. An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer

    Nature Communications, Vol. 8

  2. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth

    Journal of Hematology and Oncology, Vol. 10, Núm. 1, pp. 1-12

  3. The Usefulness of Bone Biomarkers for Monitoring Treatment Disease: A Comparative Study in Osteolytic and Osteosclerotic Bone Metastasis Models

    Translational Oncology, Vol. 10, Núm. 2, pp. 255-261

2016

  1. Erratum: Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1 (Oncogene (2016) 35 (2852-2861) DOI:10.1038/onc.2015.344)

    Oncogene

  2. Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis

    Journal of Pathology, Vol. 239, Núm. 4, pp. 438-449

  3. Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1

    Oncogene, Vol. 35, Núm. 22, pp. 2852-2861

2015

  1. Sphere-derived tumor cells exhibit impaired metastasis by a host-mediated quiescent phenotype

    Oncotarget, Vol. 6, Núm. 29, pp. 27288-27303

2014

  1. A gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer

    Oncogene, Vol. 33, Núm. 43, pp. 5090-5099

  2. MiRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization

    Molecular Oncology, Vol. 8, Núm. 3, pp. 689-703

  3. New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations

    International Journal of Cancer, Vol. 135, Núm. 11, pp. 2516-2527

  4. RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive manner

    Molecular Oncology, Vol. 8, Núm. 2, pp. 196-206

  5. The oncolytic adenovirus Δ24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activity

    Journal of Bone and Mineral Research, Vol. 29, Núm. 10, pp. 2287-2296

2013

  1. MiR-326 associates with biochemical markers of bone turnover in lung cancer bone metastasis

    Bone, Vol. 52, Núm. 1, pp. 532-539

2012

  1. Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival

    Cancer Biomarkers, Vol. 10, Núm. 1, pp. 35-41

  2. Estudio del valor pronóstico de nuevos mediadores del proceso metastásico en el cáncer de pulmón

    Anales del sistema sanitario de Navarra, Vol. 35, Núm. 1, pp. 178-179

  3. Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis

    Clinical Cancer Research, Vol. 18, Núm. 4, pp. 969-980

  4. Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma

    American Journal of Respiratory and Critical Care Medicine, Vol. 186, Núm. 1, pp. 96-105